PRPO vs TLRY · rev $13.7M vs rev $915.5M
Precipio Inc (PRPO) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Precipio Inc (PRPO) is a diagnostics & research company listed on NASDAQ.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported PRPO revenue for 2026-06-30 was $13.7M. Net income was -$1.7M. PRPO currently screens at market cap $39.0M.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
PRPO currently screens at market cap $39.0M. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the PRPO and TLRY stock pages for the full models.
Not investment advice.